{"organizations": [], "uuid": "4b553ef627418f30162456ff23b88552f5b9c4cb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-entered-in/brief-novabay-pharmaceuticals-entered-into-purchase-agreement-for-sale-of-1-7-mln-common-shares-par-value-0-01-share-idUSFWN1PW11O", "country": "US", "domain_rank": 408, "title": "BRIEF-Novabay Pharmaceuticals Entered Into Purchase Agreement For Sale Of 1.7 Mln Common Shares, Par Value $0.01/Share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-06T21:23:00.000+02:00", "replies_count": 0, "uuid": "4b553ef627418f30162456ff23b88552f5b9c4cb"}, "author": "", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-entered-in/brief-novabay-pharmaceuticals-entered-into-purchase-agreement-for-sale-of-1-7-mln-common-shares-par-value-0-01-share-idUSFWN1PW11O", "ord_in_thread": 0, "title": "BRIEF-Novabay Pharmaceuticals Entered Into Purchase Agreement For Sale Of 1.7 Mln Common Shares, Par Value $0.01/Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novabay pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 24 PM / Updated 24 minutes ago BRIEF-Novabay Pharmaceuticals Entered Into Purchase Agreement For Sale Of 1.7 Mln Common Shares, Par Value $0.01/Share Reuters Staff 1 Min Read \nFeb 6 (Reuters) - Novabay Pharmaceuticals Inc: \n* NOVABAY PHARMACEUTICALS - ENTERED INTO SHARE PURCHASE AGREEMENT ON FEB 5, 2018 FOR SALE OF 1.7 MILLION SHARES OF COMMON STOCK, PAR VALUE $0.01 PER SHARE Source text: [ bit.ly/2GRs8jo ] Further company coverage:", "external_links": [], "published": "2018-02-06T21:23:00.000+02:00", "crawled": "2018-02-06T21:42:36.004+02:00", "highlightTitle": ""}